| **Outcome**                                                                                                                                                                   | **N of trials** | **N of patients** | **RR [95% CI]**   | **I2** |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------|-------------------|-------------------|--------|
| Clinical success                                                                                                                                                              | 14              | 2,590             | 1.01 [0.98-1.04]  | 4%     |
|   Clinical success - males                                                                                                                                                     | 5               | 794               | 0.97 [0.91-1.03]  | 20%    |
|   Clinical success - females                                                                                                                                                   | 5               | 773               | 1.04 [0.97-1.11]  | 0%     |
|   Clinical success - quinolones                                                                                                                                                | 9               | 1,715             | 1.01 [0.97, 1.04] | 26%    |
|   Clinical success - any antibiotic                                                                                                                                            | 5               | 875               | 1.01 [0.94, 1.08] | 0%     |
|   Clinical success - bacteremia                                                                                                                                                | 6               | 832               | 1.02 [0.95, 1.10] | 0%     |
| Microbiological cure                                                                                                                                                          | 11              | 1,719             | 0.98 [0.94-1.02]  | 58%    |
| Relapse or re-infection                                                                                                                                                       | 10              | 1,680             | 1.11 [0.95-1.31]  | 4%     |
| Death                                                                                                                                                                         | 8               | 3,976             | 0.87 [0.68-1.13]  | 0%     |
| Any adverse event                                                                                                                                                             | 9               | 2,502             | 0.99 [0.88-1.12]  | 33%    |
| Adverse events requiring discontinuation                                                                                                                                      | 6               | 905               | 0.48 [0.19-1.21]  | 0%     |
| Diaarhea                                                                                                                                                                      | 8               | 1,427             | 0.71 [0.48-1.04]  | 0%     |
| Abbreviations - RR: Risk ratio; CI: Confidence interval; N: Number. RR >1 favor short for success and cure; <br>RR<1 and favor short for relapse, re-infection, and death<br> |                 |                   |                   |        |
|                                                                                                                                                                               |                 |                   |                   |        |
